Natural killer cells: role in local tumor growth and metastasis
Open accessThe DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
Historically, the name of natural killer (NK) cells came from their natural ability to kill tumor cells in vitro. From the 1970s to date, accumulating data highlighted the importance of NK cells in host immune response against cancer and in therapy-induced antitumor response. The recognition and the lysis of tumor cells by NK cells are regulated by a complex balance of inhibitory and activating signals. This review summarizes NK cell mechanisms to kill cancer cells, their role in host immune responses against tumor growth or metastasis, and their implications in antitumor immunotherapies via cytokines, antibodies, or in combination with other therapies. The regulatory role of NK cells in autoimmunity is also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functions of natural killer cells
Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S. (2008) · Nature Immunology · doi:10.1038/ni1582 · Cited by 3,943 · cited 1×
“Biologics: Targets and Therapy 2012:6 inflammatory response, the production of chemokines and cytokines, and the lysis of sensitive target cells.(9,10) NK cells represent 5% to 20% of peripheral blood mononuclear cells, usually defined as CD16+ CD56+ CD3- cells and are also found in many tissues such as liver, periton…”
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999 · cited 6×
“72 The density of NCR on the cell surface varies with individuals and there is a direct correlation between NCR expression on human NK cells and their capacity to kill tumor cells.”
InfluentialBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Grimm, E. A., Mazumder, A., Zhang, H. Z., & Rosenberg, S. A. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.6.1823 · Cited by 2,204 · cited 1×
“The observation that IL-2 increased in vitro the cytotoxic activity of NK cells against tumor cells 99 has been conducted to perform clinical trials with adoptive transfer of high doses of this cytokine in patients with metastatic melanoma or renal cell carcinoma.”
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161 · cited 7×
“Shortly thereafter, NK cells were shown to eliminate circulating tumor cells in mice,(22) but also to kill spontaneously cells deficient for MHC-I.(4) The generation of mice genetically deficient for NK cells or depleted of these cells by antibodies, highlighted that NK cells have a role in immunosurveillance of cance…”
InfluentialNATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113 · cited 1×
“IFN-γ has been also described to enhance NK cell cytotoxicity by overexpressing adhesion molecules or by increasing the sensitivity of tumor cells to cytotoxicity mediated by granule release or death receptor engagement.(40) TRAIL expression on murine liver NK cells is dependent on IFN-γ expression and contributes to…”
Atkins, M. B., Lotze, M. T., Dutcher, J. P., Fisher, R. I., Weiss, G., Margolin, K., Abrams, J., Sznol, M., Parkinson, D., Hawkins, M., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2105 · Cited by 2,048 · cited 1×
“of high doses of this cytokine in patients with metastatic melanoma or renal cell carcinoma.(100,101) Due to systemic”
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,905
Kiessling, R., Klein, E., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050208 · Cited by 1,824 · cited 1×
“Introduction to natural killer cells in antitumor immune response Natural killer (NK) cells were discovered in humans and mice in 1975 due to specific functional criteria corresponding to their ability to lyse certain tumor cells in the absence of prior stimulation.(1) They possess a morphology of large granular lymph…”
Kägi, D., Ledermann, B., Bürki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M., & Hengartner, H. (1994) · Nature · doi:10.1038/369031a0 · Cited by 1,757 · cited 1×
“cells, suggesting that this molecule is required for NK cell cytotoxicity.(32) Moreover, many studies have shown”
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.10.3146 · Cited by 1,449 · cited 1×
“The CD56 subpopulation predominates in lymph nodes, expresses no or low levels of CD16, displays little cytotoxicity, and mainly produces cytokines upon activation (Figure 3).(16) CD56 is not expressed on mouse NK cells, but recently Hayakawa and Smyth(17) categorized these cells depending on their CD27 expression.”
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H. (2005) · Nature · doi:10.1038/nature03884 · Cited by 1,308 · cited 1×
“activating ligand (eg, NKG2DL) expression via DNA damage response.(119) Figure 4 summarizes the different mechanisms implicated into NK cell response against tumor cells.”
Imai, K., Matsuyama, S., Miyake, S., Suga, K., & Nakachi, K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03231-1 · Cited by 1,190 · cited 1×
“An 11-year follow-up survey has shown that a low NK cell activity is associated with an increased cancer risk.(91) This was confirmed in several human malignancies.”
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
Diefenbach, A., Jensen, E. R., Jamieson, A. M., & Raulet, D. H. (2001) · Nature · doi:10.1038/35093109 · Cited by 1,083 · cited 1×
“Especially the lack of MHC-I expression, overexpression of NKG2D ligands (H60, Rae1β, Rae1δ, Rae1γ, Mult-1), or costimulatory signals makes the tumor more susceptible to lysis by NK cells.(84) Moreover, engagement of NCR complements NKG2D pathway in the killing of tumor cells by NK cells.”
Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance
Cao, X., Cai, S. F., Fehniger, T. A., Song, J., Collins, L. I., Piwnica-Worms, D. R., & Ley, T. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.08.014 · Cited by 1,035 · cited 1×
“that perforin is important for the immunosurveillance of several spontaneous malignancies(33) whereas the role of granzymes is less characterized.(34) • Death receptor mediated apoptosis: The death of the”
Groh, V, Bahram, S., Bauer, S., Herman, A., Beauchamp, M., & Spies, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12445 · Cited by 1,017 · cited 1×
“Expression of NKG2D ligands is observed on many tumor cell lines and tumor tissues.(70,71) More specifically expressed on NK cells, the principal NCR are NKp46, NKp44, and NKp30.”
Biology and clinical relevance of human natural killer cells
Robertson, M., & Ritz, J. (1990) · Blood · doi:10.1182/blood.v76.12.2421.2421 · Cited by 931
Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
Lanier, L. L., Corliss, B. C., Wu, J., Leong, C., & Phillips, J. H. (1998) · Nature · doi:10.1038/35642 · Cited by 904 · cited 1×
“Most of the adapter proteins (FcεRγI, CD3ζ, DAP12, and DAP10) contain immunoreceptor tyrosine-based activation motif in their cytoplasmic domains, which enable them to associate with ZAP70 and/or proteins of syk kinases family.(61,62)”
Gong, J.-H., Maki, G., & Klingemann, H.-G. (1994) · PubMed · Cited by 870
Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1505 · Cited by 798 · cited 4×
“NKp30 is a glycoprotein of 30 kDa that associates with the adapter molecules CD3ζ and FcεRγI.(73) Its expres-”
InfluentialTakeda, K., Hayakawa, Y., Smyth, M. J., Kayagaki, N., Yamaguchi, N., Kakuta, S., Iwakura, Y., Yagita, H., & Okumura, K. (2001) · Nature Medicine · doi:10.1038/83416 · Cited by 775 · cited 2×
“TRAIL expression on murine liver NK cells is dependent on IFN-γ expression and contributes to the natural antimetastatic role of these NK cells.(36) IFN-γ induced TRAIL expression is also implicated in the IL-12 mediated anti-metastatic effect.”
CD27 Dissects Mature NK Cells into Two Subsets with Distinct Responsiveness and Migratory Capacity
Hayakawa, Y., & Smyth, M. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1517 · Cited by 749
Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2065 · Cited by 748 · cited 3×
“The blocking of NKp44 by monoclonal antibodies induces a partial inhibition of the cytolytic activity against some tumor cells and this inhibition is strongly enhanced by the addition of antibodies blocking NKp46.(78) NKp30 is a glycoprotein of 30 kDa that associates with the adapter molecules CD3ζ and FcεRγI.”
InfluentialLjunggren, H. G., & Kärre, K. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.1745 · Cited by 736 · cited 5×
“NK cells preferentially lyse cells expressing few or no MHC-I.(44) The sensitivity of cells with low MHC-I expression to NK cell lysis may be prevented by the re-expression of these molecules.”
InfluentialBrandt, C. S., Baratin, M., Yi, E. C., Kennedy, J., Gao, Z., Fox, B., Haldeman, B., Ostrander, C. D., Kaifu, T., Chabannon, C., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090681 · Cited by 706 · cited 1×
“cells by binding to factor BAT3 (HLA-B associated transcript (3) or to B7-H6 present on their surface.(81,82)”
Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.
Angiolillo, A. L., Sgadari, C., Taub, D. D., Liao, F., Farber, J. M., Maheshwari, S., Kleinman, H. K., Reaman, G. H., & Tosato, G. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.155 · Cited by 705 · cited 2×
“This cytokine inhibits proliferation of tumor cells in vitro and indirectly the tumor growth in vivo by inducing the antiangiogenic factors, IP-10.(39) IFN-γ has been also described to enhance NK cell cytotoxicity by overexpressing adhesion molecules or by increasing the sensitivity of tumor cells to cytotoxicity medi…”
Comparative studies of human FcRIII-positive and negative natural killer cells.
Nagler, A., Lanier, L. L., Cwirla, S., & Phillips, J. H. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.10.3183 · Cited by 696 · cited 1×
“These cells possess a high cytotoxic potential.(15) The CD56 subpopulation predominates in lymph nodes, expresses no or low levels of CD16, displays little cytotoxicity, and mainly produces cytokines upon activation (Figure 3).”
Activation, coactivation, and costimulation of resting human natural killer cells
Bryceson, Y. T., March, M. E., Ljunggren, H., & Long, E. O. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00457.x · Cited by 650 · cited 1×
“cell, NK cells will drop, at this junction, perforin and granzyme molecules inducing the lysis of the target cell.(31)”
Bielekova, B., Catalfamo, M., Reichert-Scrivner, S., Packer, A., Cerna, M., Waldmann, T. A., McFarland, H., Henkart, P. A., & Martin, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601335103 · Cited by 597 · cited 1×
“This augmentation of CD56 NK cells is correlated with the suppression of the disease activity.(129) NK cells can also promote autoimmune diseases, ie, autoimmune diabetes is prevented in nonobese-diabetic mice by blocking the activating NK cell receptor NKG2D.”
Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.953 · Cited by 579 · cited 1×
“NKp46, the first identified NCR, is a 46 kDa glycoprotein with a transmembrane domain that interacts with the adapter molecule CD3ζ.(59,76) The activation of NKp46 leads to mobilization of calcium in the development of cytolytic activity and cytokine production.”
Perforin-Mediated Cytotoxicity Is Critical for Surveillance of Spontaneous Lymphoma
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., MacGregor, D., Godfrey, D. I., & Trapani, J. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.755 · Cited by 576 · cited 1×
“32 Moreover, many studies have shown that perforin is important for the immunosurveillance of several spontaneous malignancies 33 whereas the role of granzymes is less characterized.”
Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis
Street, S. E. A., Cretney, E., & Smyth, M. J. (2001) · Blood · doi:10.1182/blood.v97.1.192 · Cited by 572 · cited 1×
“Indeed, IFN-γ produced by NK cells contributes to eliminate tumor metastases and sarcoma induced by methylcholanthrene in a murine model.(38) This cytokine inhibits proliferation of tumor cells in vitro and indirectly the tumor growth in vivo by inducing the antiangiogenic factors, IP-10.”
Zamai, L., Ahmad, M., Bennett, I. M., Azzoni, L., Alnemri, E. S., & Perussia, B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2375 · Cited by 566
p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C., Moretta, L., & Moretta, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1129 · Cited by 554 · cited 4×
“70,71 More specifically expressed on NK cells, the principal NCR are NKp46, NKp44, and NKp30.”
InfluentialRegulation of the Natural Killer Cell Receptor Repertoire
Raulet, D. H., Vance, R. E., & McMahon, C. W. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.291 · Cited by 521 · cited 1×
“6 This new model complements the hypothesis of “missing-self” by explaining why NK cells kill tumor cells expressing MHC-I molecules or save autologous cells with absent MHC-I expression (Figure 2).”
Bryceson, Y. T., March, M. E., Barber, D. F., Ljunggren, H.-G., & Long, E. O. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051143 · Cited by 515
Smyth, M. J., Cretney, E., Takeda, K., Wiltrout, R. H., Sedger, L. M., Kayagaki, N., Yagita, H., & Okumura, K. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.661 · Cited by 512 · cited 1×
“24 Additionally, IFN-γ plays a role in the stimulation of dendritic cells (DC).”
Costello, R. T., Sivori, S., Marcenaro, E., Lafage-Pochitaloff, M., Mozziconacci, M.-J., Reviron, D., Gastaut, J.-A., Pende, D., Olive, D., & Moretta, A. (2002) · Blood · doi:10.1182/blood.v99.10.3661 · Cited by 500 · cited 1×
“The density of NCR on the cell surface varies with individuals and there is a direct correlation between NCR expression on human NK cells and their capacity to kill tumor cells.(75) NKp46, the first identified NCR, is a 46 kDa glycoprotein with a transmembrane domain that interacts with the adapter molecule CD3ζ.”
Effect of NKG2D ligand expression on host immune responses
Champsaur, M., & Lanier, L. L. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00893.x · Cited by 488 · cited 1×
“It is associated with the adapter molecule DAP10 in humans, and DAP10 and DAP12 in mice.(67,68) Binding of”
The MHC class I antigen presentation pathway: strategies for viral immune evasion
Hewitt, E. W. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01738.x · Cited by 487 · cited 1×
“4,27 In fact, downregulation of MHC-I is observed during tumor transformation 28 or viral infection 29 and prevents the binding of inhibitory receptors of NK cells to the target cell.”
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46
Walzer, T., Bléry, M., Chaix, J., Fuseri, N., Chasson, L., Robbins, S. H., Jaeger, S., André, P., Gauthier, L., Daniel, L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609692104 · Cited by 476 · cited 1×
“1 for mice), NKp46 is exclusively expressed by all NK cells in both species.(18) A B”
Cantoni, C., Bottino, C., Vitale, M., Pessino, A., Augugliaro, R., Malaspina, A., Parolini, S., Moretta, L., Moretta, A., & Biassoni, R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.787 · Cited by 452 · cited 4×
“NKp44 is a 44 kDa glycoprotein whose expression is inducible by IL-2, suggesting that it could contribute to the increased efficiency of activated NK cells to lyse tumor cells.(72) NKp44 acts in association with the immunoreceptor tyrosine-based activation motif on the adapter molecule DAP12.”
InfluentialNATURAL KILLER CELL DEVELOPMENTAL PATHWAYS: A Question of Balance
Di Santo, J. P. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090700 · Cited by 448
Houchins, J. P., Yabe, T., McSherry, C., & Bach, F. H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.4.1017 · Cited by 447
Natural Killer Cells and Cancer
(2003) · Advances in Cancer Research · doi:10.1016/s0065-230x(03)90004-2 · Cited by 438 · cited 1×
“Biologics: Targets and Therapy 2012:6 inflammatory response, the production of chemokines and cytokines, and the lysis of sensitive target cells.(9,10) NK cells represent 5% to 20% of peripheral blood mononuclear cells, usually defined as CD16+ CD56+ CD3- cells and are also found in many tissues such as liver, periton…”
Mocikat, R., Braumüller, H., Gumy, A., Egeter, O., Ziegler, H., Reusch, U., Bubeck, A., Louis, J., Mailhammer, R., Riethmüller, G., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00264-4 · Cited by 433
In vivo natural killer cell activities revealed by natural killer cell-deficient mice
Kim, S., Iizuka, K., Aguila, H. L., Weissman, I. L., & Yokoyama, W. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050588297 · Cited by 424
Sivori, S., Pende, D., Bottino, C., Marcenaro, E., Pessino, A., Biassoni, R., Moretta, L., & Moretta, A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199905)29:05<1656::aid-immu1656>3.0.co;2-1 · Cited by 422 · cited 1×
“Monoclonal antibodies against NKp46 block the lysis of a wide range of tumor cells showing that this receptor plays a major role in NK cell cytotoxicity.(77) This function of NKp46 is negatively regulated by the interaction between inhibitory receptors and MHC-I.”
High-level IL-12 production by human dendritic cells requires two signals
Snijders, A. (1998) · International Immunology · doi:10.1093/intimm/10.11.1593 · Cited by 420 · cited 2×
“In combination with CD40 engagement, IFN-γ induces IL-12 production by DCs. 41 In this way, NK cells contribute indirectly to tumor control by helping the initiation and maintenance of an efficient T cell-mediated antitumor response via a crosstalk with DC. 42,43”
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Smyth, M. J., Crowe, N. Y., & Godfrey, D. I. (2001) · International Immunology · doi:10.1093/intimm/13.4.459 · Cited by 379 · cited 4×
“However, some biotherapies are linked with changes of circulating NK cells compartment.”
InfluentialVan Tendeloo, V. F., Van de Velde, A., Van Driessche, A., Cools, N., Anguille, S., Ladell, K., Gostick, E., Vermeulen, K., Pieters, K., Nijs, G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008051107 · Cited by 377 · cited 1×
“114 In a Phase I clinical trial with melanoma patients, DC derived-exosomes enhanced NKG2D-dependent function of NK cells in half of the patients.”
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Smyth, M. J. (2008) · International Immunology · doi:10.1093/intimm/dxn028 · Cited by 377
Pogge von Strandmann, E., Simhadri, V. R., von Tresckow, B., Sasse, S., Reiners, K. S., Hansen, H. P., Rothe, A., Böll, B., Simhadri, V. L., Borchmann, P., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.10.010 · Cited by 374
Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection
Kelly, J. M., Darcy, P. K., Markby, J. L., Godfrey, D. I., Takeda, K., Yagita, H., & Smyth, M. J. (2002) · Nature Immunology · doi:10.1038/ni746 · Cited by 356 · cited 1×
“This collaboration can help to induce a T cell-mediated antitumor immunity.(97) After the implantation of MHC-I low tumor cells in mice, the release of IFN-γ by NK cells stimulate the matura-”
NKG2D function protects the host from tumor initiation
Smyth, M. J., Swann, J., Cretney, E., Zerafa, N., Yokoyama, W. M., & Hayakawa, Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050994 · Cited by 342 · cited 1×
“86 However, Smyth et al 25,87 showed that mice deficient in NK cells are more susceptible to methylcholanthrene-induced sarcomas, demonstrating that NK cells play a role in tumor immunosurveillance.”
Wagtmann, N., Rajagopalan, S., Winter, C. C., Peruui, M., & Long, E. O. (1995) · Immunity · doi:10.1016/1074-7613(95)90069-1 · Cited by 335
Pende, D., Cantoni, C., Rivera, P., Vitale, M., Castriconi, R., Marcenaro, S., Nanni, M., Biassoni, R., Bottino, C., Moretta, A., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1076::aid-immu1076>3.0.co;2-y · Cited by 334 · cited 1×
“Moreover, engagement of NCR complements NKG2D pathway in the killing of tumor cells by NK cells.(85) Little is known about the mechanism of NK cell migration in tumor, but selectins seem to play a role in this recruitment.”
Dendritic Cell-Derived Exosomes for Cancer Immunotherapy: What's Next?
Viaud, S., Théry, C., Ploix, S., Tursz, T., Lapierre, V., Lantz, O., Zitvogel, L., & Chaput, N. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3276 · Cited by 332 · cited 1×
“In a Phase I clinical trial with melanoma patients, DC derived-exosomes enhanced NKG2D-dependent function of NK cells in half of the patients.(115) Indirectly, immunotherapy protocols targeting an oncogenic viral protein(116) or the recruitment of antigenpresenting cells(117) boost NK cell response.”
Martin, M. P., Nelson, G., Lee, J.-H., Pellett, F., Gao, X., Wade, J., Wilson, M. J., Trowsdale, J., Gladman, D., & Carrington, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.2818 · Cited by 328
MHC antigens and tumor escape from immune surveillance
(2001) · Advances in Cancer Research · doi:10.1016/s0065-230x(01)83005-0 · Cited by 305 · cited 1×
“4,27 In fact, downregulation of MHC-I is observed during tumor transformation 28 or viral infection 29 and prevents the binding of inhibitory receptors of NK cells to the target cell.”
Carretero, M., Cantoni, C., Bellón, T., Bottino, C., Biassoni, R., Rodríguez, A., Pérez‐Villar, J. J., Moretta, L., Moretta, A., & López‐Botet, M. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270230 · Cited by 281
Sutherland, C. L., Chalupny, N. J., Schooley, K., VandenBos, T., Kubin, M., & Cosman, D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.671 · Cited by 276 · cited 1×
“NKG2D ligands, such as MICA or MICB, leads to an increase in proliferation, cytotoxicity, and production of cytokines and chemokines (IFN-γ, GM-CSF, TNF-α).(69) Expression of NKG2D ligands is observed on many tumor cell lines and tumor tissues.”
Impairment of NK Cell Function by NKG2D Modulation in NOD Mice
Ogasawara, K., Hamerman, J. A., Hsin, H., Chikuma, S., Bour-Jordan, H., Chen, T., Pertel, T., Carnaud, C., Bluestone, J. A., & Lanier, L. L. (2003) · Immunity · doi:10.1016/s1074-7613(02)00505-8 · Cited by 276 · cited 2×
“129 NK cells can also promote autoimmune diseases, ie, autoimmune diabetes is prevented in nonobese-diabetic mice by blocking the activating NK cell receptor NKG2D.”
Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells
Street, S. E. A., Hayakawa, Y., Zhan, Y., Lew, A. M., MacGregor, D., Jamieson, A. M., Diefenbach, A., Yagita, H., Godfrey, D. I., & Smyth, M. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031981 · Cited by 264
Olcese, L., Cambiaggi, A., Semenzato, G., Bottino, C., Moretta, A., & Vivier, E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5083 · Cited by 262 · cited 1×
“Most of the adapter proteins (FcεRγI, CD3ζ, DAP12, and DAP10) contain immunoreceptor tyrosine-based activation motif in their cytoplasmic domains, which enable them to associate with ZAP70 and/or proteins of syk kinases family.(61,62)”
Le Dréan, E., Vély, F., Olcese, L., Cambiaggi, A., Guia, S., Krystal, G., Gervois, N., Moretta, A., Jotereau, F., & Vivier, E. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01<264::aid-immu264>3.0.co;2-o · Cited by 254 · cited 1×
“50,54 All inhibitory receptors are found by overlapping NK cell subpopulations since each cell expresses only a few types of inhibitory receptors.”
CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence
Petrie, E. J., Clements, C. S., Lin, J., Sullivan, L. C., Johnson, D., Huyton, T., Heroux, A., Hoare, H. L., Beddoe, T., Reid, H. H., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072525 · Cited by 245
Safety and immunologic effects of IL-15 administration in nonhuman primates
Berger, C., Berger, M., Hackman, R. C., Gough, M., Elliott, C., Jensen, M. C., & Riddell, S. R. (2009) · Blood · doi:10.1182/blood-2008-12-189266 · Cited by 244 · cited 1×
“IL-15 shares similar properties with IL-2 and Berger et al 102 showed that intermittent administration of IL-15 should be considered in clinical studies.”
Antibodies, Fc receptors and cancer
Nimmerjahn, F., & Ravetch, J. V. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.01.005 · Cited by 234 · cited 1×
“dominant component of antibody based immunotherapy against tumors.(64) Recently, CD16 has been implicated in the”
Viral modulation of NK cell immunity
Lodoen, M. B., & Lanier, L. L. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1066 · Cited by 234 · cited 1×
“The first checkpoint is the expression of MHC-I molecules.(4,27) In fact, downregulation of MHC-I is observed during tumor transformation(28) or viral infection(29) and prevents the binding of inhibitory receptors of NK cells to the target cell.”
DC-NK cell cross talk as a novel CD4+ T-cell–independent pathway for antitumor CTL induction
Adam, C., King, S., Allgeier, T., Braumüller, H., Lüking, C., Mysliwietz, J., Kriegeskorte, A., Busch, D. H., Röcken, M., & Mocikat, R. (2005) · Blood · doi:10.1182/blood-2004-09-3775 · Cited by 233
Natural Killer Cells: From No Receptors to Too Many
Lanier, L. L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80280-0 · Cited by 222
Namekawa, T., Snyder, M. R., Yen, J.-H., Goehring, B. E., Leibson, P. J., Weyand, C. M., & Goronzy, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.1138 · Cited by 210 · cited 1×
“131 In humans, the predisposition to rheumatoid arthritis, 132 psoriatic arthritis, 133 scleroderma, 134 and psoriasis vulgaris 135 is linked to the expression of certain KIR and HLA alleles, but the precise role of NK cells in these diseases is still under investigation.”
Lauwerys, B. R., Garot, N., Renauld, J.-C., & Houssiau, F. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1847 · Cited by 203 · cited 1×
“Also other cytokines, such as IL-12 and IL-18, synergistically enhance NK cytotoxicity against tumor targets and IFN-γ production by NK cells.(103,104) Tumor-targeted monoclonal antibodies can induce NK cell antibody-dependent cell-mediated cytotoxicity and the rapid degranulation of NK cells results in tumor cell des…”
Natural killer cells determine the outcome of B cell–mediated autoimmunity
Shi, F.-D., Wang, H.-B., Li, H., Hong, S., Taniguchi, M., Link, H., Kaer, L. V., & Ljunggren, H.-G. (2000) · Nature Immunology · doi:10.1038/79792 · Cited by 187 · cited 1×
“NK cells can either augment or ameliorate autoimmune diseases.(125,126) A reduction of circulating NK cells has been shown in diverse autoimmune diseases, which contributed to an impaired NK activity.”
In vivo natural reactivity of mice against tumor cells
Riccardi, C., Santoni, A., Barlozzari, T., Puccetti, P., & Herberman, R. B. (1980) · International Journal of Cancer · doi:10.1002/ijc.2910250409 · Cited by 176 · cited 1×
“21 Shortly thereafter, NK cells were shown to eliminate circulating tumor cells in mice, 22 but also to kill spontaneously cells deficient for MHC-I.”
Autoimmunity associated with immunotherapy of cancer
Amos, S. M., Duong, C. P. M., Westwood, J. A., Ritchie, D. S., Junghans, R. P., Darcy, P. K., & Kershaw, M. H. (2011) · Blood · doi:10.1182/blood-2011-01-325266 · Cited by 171 · cited 1×
“Moreover autoimmunity is associated with immunotherapy of cancer.(123) Several studies suggested that NK cells play a role at the different stages of the autoimmune response.”
Bloushtain, N., Qimron, U., Bar-Ilan, A., Hershkovitz, O., Gazit, R., Fima, E., Korc, M., Vlodavsky, I., Bovin, N. V., & Porgador, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2392 · Cited by 165 · cited 1×
“and NKp30 bind to heparan sulfates on the surface of tumor cells.(79,80) In addition, NKp30 is involved in the lysis of tumor”
Ortaldo, J. R., Oldham, R. K., Cannon, G. C., & Herberman, R. B. (1977) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/59.1.77 · Cited by 163 · cited 1×
“From their discovery, NK cells were described as white blood cells able to lyse tumor cells such as K562, a tumor cell line generated from a patient with chronic leukemia.(21) Shortly thereafter, NK cells were shown to eliminate circulating tumor cells in mice,(22) but also to kill spontaneously cells deficient for MH…”
Enhanced In Vivo Growth of Lymphoma Tumors in the Absence of the NK-Activating Receptor NKp46/NCR1
Halfteck, G. G., Elboim, M., Gur, C., Achdout, H., Ghadially, H., & Mandelboim, O. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801878 · Cited by 162 · cited 1×
“duct to a more aggressive tumor growth in NK cell deficient mice compared to wild type mice.(26)”
Hecht, M.-L., Rosental, B., Horlacher, T., Hershkovitz, O., De Paz, J. L., Noti, C., Schauer, S., Porgador, A., & Seeberger, P. H. (2009) · Journal of Proteome Research · doi:10.1021/pr800747c · Cited by 161 · cited 1×
“and NKp30 bind to heparan sulfates on the surface of tumor cells.(79,80) In addition, NKp30 is involved in the lysis of tumor”
Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo
Koh, C. Y., Blazar, B. R., George, T., Welniak, L. A., Capitini, C. M., Raziuddin, A., Murphy, W. J., & Bennett, M. (2001) · Blood · doi:10.1182/blood.v97.10.3132 · Cited by 160
Suzuki, Y., Hamamoto, Y., Ogasawara, Y., Ishikawa, K., Yoshikawa, Y., Sasazuki, T., & Muto, M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22517.x · Cited by 152 · cited 1×
“131 In humans, the predisposition to rheumatoid arthritis, 132 psoriatic arthritis, 133 scleroderma, 134 and psoriasis vulgaris 135 is linked to the expression of certain KIR and HLA alleles, but the precise role of NK cells in these diseases is still under investigation.”
A Structural Basis for the Association of DAP12 with Mouse, but Not Human, NKG2D
Rosen, D. B., Araki, M., Hamerman, J. A., Chen, T., Yamamura, T., & Lanier, L. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2470 · Cited by 146 · cited 1×
“It is associated with the adapter molecule DAP10 in humans, and DAP10 and DAP12 in mice.(67,68) Binding of”
Innate immunity and autoimmunity: from self-protection to self-destruction
Shi, F., Ljunggren, H., & Sarvetnick, N. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01821-4 · Cited by 145 · cited 1×
“Autoimmune diseases are a multistep process caused by inappropriate activation of cells of the adaptive immune system (T and B cells) which results in cell-specific, organ-specific, or systemic tissue damage.(121) Autoimmunity has been linked to cancer, for example, patients with scleroderma have an increased risk to…”
Carretero, M., Palmieri, G., Llano, M., Tullio, V., Santoni, A., Geraghty, D. E., & López‐Botet, M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199804)28:04<1280::aid-immu1280>3.0.co;2-o · Cited by 143 · cited 2×
“55 CD94 has no cytoplasmic signalization domain while the receptor NKG2A contains two ITIM.”
Trinchieri, G. (1995) · Seminars in Immunology · doi:10.1006/smim.1995.0012 · Cited by 142 · cited 1×
“• Interferon-γ effector functions: After activation, NK cells secrete various cytokines such as interferon γ (IFN-γ), TNF-α, granulocyte–macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-10, or IL-13 and their antitumor activities can be mediated by IFN-γ.(37) Indeed, IFN-γ produced by NK cells contribut…”
Association of killer cell immunoglobulin‐like receptors with scleroderma
Momot, T., Koch, S., Hunzelmann, N., Krieg, T. M., Ulbricht, K. U., Schmidt, R. E., & Witte, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20216 · Cited by 141 · cited 1×
“131 In humans, the predisposition to rheumatoid arthritis, 132 psoriatic arthritis, 133 scleroderma, 134 and psoriasis vulgaris 135 is linked to the expression of certain KIR and HLA alleles, but the precise role of NK cells in these diseases is still under investigation.”
Anti-GD2 Antibody Therapy for GD2-Expressing Tumors
Navid, F., M. Santana, V., & C. Barfield, R. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910791054167 · Cited by 135 · cited 1×
“105 109 Moreover, in a Phase I trial, coadministration of IL-12 with trastuzumab enhances the antitumor response induced by the antibody.”
Regulatory NK-Cell Functions in Inflammation and Autoimmunity
Lünemann, A., Lünemann, J. D., & Münz, C. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00035 · Cited by 132 · cited 1×
“Biologics: Targets and Therapy 2012:6 can also prevent and limit adaptive autoimmune responses.(120) Autoimmune diseases are a multistep process caused by inappropriate activation of cells of the adaptive immune system (T and B cells) which results in cell-specific, organ-specific, or systemic tissue damage.”
Human uterine natural killer cells.
King, A., Burrows, T. D., & Loke, Y. W. (1996) · PubMed · Cited by 132
Garnock-Jones, K. P., Keating, G. M., & Scott, L. J. (2010) · Drugs · doi:10.2165/11203700-000000000-00000 · Cited by 130
Ho, E. L., Heusel, J. W., Brown, M. G., Matsumoto, K., Scalzo, A. A., & Yokoyama, W. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6320 · Cited by 128 · cited 2×
“NKG2D, unlike the other NKG2 receptors, does not have an ITIM sequence and is not associated with CD94.(66) It is expressed on most NK cells but also on γδ and CD8+”
KIR/HLA Interactions and Pathogen Immunity
Jamil, K., & Khakoo, S. (2011) · Journal of Biomedicine and Biotechnology · doi:10.1155/2011/298348 · Cited by 125
Bottino, C., Biassoni, R., Millo, R., Moretta, L., & Moretta, A. (2000) · Human Immunology · doi:10.1016/s0198-8859(99)00162-7 · Cited by 119 · cited 1×
“Molecular cloning of NCR confirmed that they were structurally distinct although they belong to the same immunoglobulin superfamily.(74) NKp46 (human and mice) and NKp30 (human) are expressed on both resting and activated NK cells, while the NKp44 receptor is only present on IL-2-activated human NK cells and a minor s…”
Hallez, S., Simon, P., Maudoux, F., Doyen, J., No�l, J.-C., Beliard, A., Capelle, X., Buxant, F., Fayt, I., Lagrost, A.-C., et al. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0501-4 · Cited by 110
Self-citationBekaii-Saab, T. S., Roda, J. M., Guenterberg, K. D., Ramaswamy, B., Young, D. C., Ferketich, A. K., Lamb, T. A., Grever, M. R., Shapiro, C. L., & Carson, W. E. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0820 · Cited by 107 · cited 1×
“Moreover, in a Phase I trial, coadministration of IL-12 with trastuzumab enhances the antitumor response induced by the antibody.(110)”
CD94/NKG2A Inhibits NK Cell Activation by Disrupting the Actin Network at the Immunological Synapse
Masilamani, M., Nguyen, C. M.-C., Kabát, J., Borrego, F., & Coligan, J. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3590 · Cited by 106 · cited 1×
“The CD94/NKG2A receptor, conserved in rodents and primates, is expressed on most NK cells and a subset of CD8+ memory T cells.(55) CD94 has no cytoplasmic signalization domain while the receptor NKG2A contains two ITIM.”
Li, Z., Lim, W. K., Mahesh, S. P., Liu, B., & Nussenblatt, R. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5187 · Cited by 103
Tumor growth impedes natural-killer-cell maturation in the bone marrow
Richards, J. O., Chang, X., Blaser, B. W., Caligiuri, M. A., Zheng, P., & Liu, Y. (2006) · Blood · doi:10.1182/blood-2005-11-4535 · Cited by 99 · cited 1×
“94 Tumor growth can disturb the functional maturation of NK cells by interrupting the IL-15 signaling pathway, 95 but further studies are necessary to better understand the immunologic basis of NK cell defects in tumor.”
Lymphocyte Subsets in a Large Cohort of Patients with Systemic Lupus Erythematosus
Erkeller-Yüksel, F., Hulstaart, F., Hannet, I., Isenberg, D. A., & Lydyard, P. M. (1993) · Lupus · doi:10.1177/096120339300200404 · Cited by 95
Winter, M. C., & Hancock, B. W. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330902750114 · Cited by 89
Aramaki, T., Ida, H., Izumi, Y., Fujikawa, K., Huang, M., Arima, K., Tamai, M., Kamachi, M., Nakamura, H., Kawakami, A., et al. (2009) · Modern Rheumatology · doi:10.1007/s10165-009-0160-6 · Cited by 85
Reschner, A., Hubert, P., Delvenne, P., Boniver, J., & Jacobs, N. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03624.x · Cited by 77 · cited 1×
“As already mentioned, NK cells collaborate with antigenpresenting cells to amplify the immune response.(96) This collaboration can help to induce a T cell-mediated antitumor immunity.”
Self-citationAndresen, L. O., Skovbakke, S. L., Persson, G., Hagemann-Jensen, M., Hansen, K. A., Jensen, H., & Skov, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1004085 · Cited by 72 · cited 1×
“therapeutic agents could inhibit secretion of inhibitory soluble NKG2D ligands.(118) A NK cell treatment combined with radia-”
Shah, A. A., & Rosen, A. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32834a5081 · Cited by 70 · cited 1×
“Autoimmunity has been linked to cancer, for example, patients with scleroderma have an increased risk to develop a tumor.(122) Moreover autoimmunity is associated with immunotherapy of cancer.”
Biron, C. A., van den Elsen, P. J., Landolfi, M. M. T., Medveczky, P. G., Kumar, V., & Terhorst, C. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.5.1704 · Cited by 67 · cited 1×
“They possess a morphology of large granular lymphocytes (Figure 1A) and their receptor genes involved in the recognition of pathogens remain in germinal configuration unlike T and B cells.(2) Thus, they differ from the T and B lymphocytes by the permanent presence of a significant fraction of educated and primed cells.”
Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcome
García‐Foncillas, J., & Díaz‐Rubio, E. (2010) · Clinical & Translational Oncology · doi:10.1007/s12094-010-0551-3 · Cited by 61
Biassoni, R. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-09789-3_4 · Cited by 56
Clement, M., Haddad, P., Soulié, A., Legros-Maïda, S., Guillet, J., Cesar, E., & Sasportes, M. (1990) · Research in Immunology · doi:10.1016/0923-2494(90)90017-s · Cited by 49 · cited 1×
“Different mechanisms are known to be involved in the destruction of tumor cells by NK cells: • Perforin/granzyme-mediated cytotoxicity: The release of cytotoxic granules composed of perforin and gran-zymes 30 is the fastest and also the most powerful way to lyse tumor cells.”
Renoux, V., Bisig, B., Langers, I., Dortu, E., Clemenceau, B., Thiry, M., Deroanne, C., Colige, A., Boniver, J., Delvenne, P., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141693 · Cited by 49 · cited 1×
“recognition of human papillomavirus by NK cells in uterine preneoplastic lesions.(65)”
Self-citationMissing Self, NK Cells, and The White Album
Lanier, L. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6565 · Cited by 48 · cited 1×
“a deficient MHC-I expression on target cells but also the expression of inducible ligands of activating NK cell receptors.(7) Consequently, these cells have the ability to”
Cheng, M., Ma, J., Chen, Y., Zhang, J., Zhao, W., Zhang, J., Wei, H., Ling, B., Sun, R., & Tian, Z. (2011) · Cell Transplantation · doi:10.3727/096368911x580536 · Cited by 47 · cited 1×
“Several NK cell lines have been established from lymphoma or peripheral blood mononuclear cells such as NK-92 19 (Figure 1B) or NKG, 20 respectively.”
Jović, V., Konjević, G. M., Radulovic, S. S., Jelić, S., & Spužić, I. (2001) · Tumori Journal · doi:10.1177/030089160108700509 · Cited by 45 · cited 1×
“For example, a decrease of NK cell activity is observed in patients with hereditary colorectal adenocarcinoma(92,93) and melanoma patients with metastatic disease have an impaired perforin-dependent NK cell cytotoxic mechanism.(94) Tumor growth can disturb the functional maturation of NK cells by interrupting the IL-1…”
Regulation of production of soluble Fcγ receptors type III in normal and pathological conditions
Moldovan, I. M., Galon, J., Maridonneau‐Parini, I., Roman‐Roman, S., Mathiot, C., Fridman, W. H., & Sautès‐Fridman, C. (1999) · Immunology Letters · doi:10.1016/s0165-2478(99)00041-3 · Cited by 43 · cited 1×
“This receptor with a transmembrane domain (FcγRIIIa) is found on the surface of NK cells but also on some DC, T lymphocytes, monocytes, and macrophages, and a glycosylphosphatidylinositol-linked receptor (FcγRIIIb) is expressed on neutrophils.(63) When”
IRF-1 Expression Is Essential for Natural Killer Cells to Suppress Metastasis
Ksienzyk, A., Neumann, B., Nandakumar, R., Finsterbusch, K., Grashoff, M., Zawatzky, R., Bernhardt, G., Häuser, H., & Kröger, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1565 · Cited by 41 · cited 1×
“In a mouse model, NK cells inhibit pulmonary metastasis formation after IFN-γ treatment.(90) Also, in humans, there is evidence that NK cells play a role in the tumor immunosurveillance.”
ANTIBODY-DIRECTED, EFFECTOR CELL-MEDIATED TUMOR DESTRUCTION
Sondel, P. M., & Hank, J. A. (2001) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70243-4 · Cited by 40 · cited 1×
“Tumor-targeted monoclonal antibodies can induce NK cell antibody-dependent cell-mediated cytotoxicity and the rapid degranulation of NK cells results in tumor cell destruction.(105) The clinical efficacy of monoclonal antibodies directed against CD20 (rituximab), Her2/neu (trastuzumab), epidermal growth factor recepto…”
Inhibitory Ly49 Receptors on Mouse Natural Killer Cells
Orr, M. T., & Lanier, L. L. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_85 · Cited by 38 · cited 5×
“21 Shortly thereafter, NK cells were shown to eliminate circulating tumor cells in mice, 22 but also to kill spontaneously cells deficient for MHC-I.”
InfluentialAlici, E. (2010) · PubMed · Cited by 35
Natural killer cells as indispensable players and therapeutic targets in autoimmunity
Shi, F., & Zhou, Q. (2010) · Autoimmunity · doi:10.3109/08916931003782122 · Cited by 34 · cited 1×
“Several studies suggested that NK cells play a role at the different stages of the autoimmune response.(124) NK cells can either augment or ameliorate autoimmune diseases.”
New twist on the regulation of NKG2D ligand expression
Cerwenka, A. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090225 · Cited by 26 · cited 1×
“Expression of NKG2D ligands is observed on many tumor cell lines and tumor tissues.(70,71) More specifically expressed on NK cells, the principal NCR are NKp46, NKp44, and NKp30.”
Alloreactive natural killer cells in hematopoietic stem cell transplantation
Pegram, H. J., Ritchie, D. S., Smyth, M. J., Wiernik, A., Prince, H. M., Darcy, P. K., & Kershaw, M. H. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.07.030 · Cited by 26 · cited 1×
“NK allogeneic recognition via their KIR repertoire has a major role in reducing the risk of relapse by inducing a graft versus leukemia effect after allogeneic hematopoietic stem cell transplantation.(113) NK cells seem important in tumor vaccination with DC, since clinical responses are correlated with superior level…”
Natural Killer Cells Require Selectins for Suppression of Subcutaneous Tumors
Sobolev, O., Stern, P., Lacy‐Hulbert, A., & Hynes, R. O. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3126 · Cited by 25 · cited 1×
“Little is known about the mechanism of NK cell migration in tumor, but selectins seem to play a role in this recruitment.(86) However, Smyth et al(25,87) showed that mice deficient in NK cells are more susceptible to methylcholanthreneinduced sarcomas, demonstrating that NK cells play a role in tumor immunosurveillanc…”
Deficient immune function of peripheral blood mononuclear cells from patients with Gardner syndrome.
Warren, R. P., Stembridge, A. M., & Gardner, E. J. (1985) · PubMed Central · Cited by 23
NK Cell-Based Cancer Immunotherapy
Stagg, J., & Smyth, M. J. (2007) · Drug News & Perspectives · doi:10.1358/dnp.2007.20.3.1092096 · Cited by 21 · cited 1×
“Role of NK cells in immune response against tumor growth and metastasis In vivo and in vitro studies have shown that NK cells can eliminate tumor cells.(83) In mice, tumor rejection is dependent”
Cancer family syndrome: Marker studies
Markowitz, J. F., Aiges, H. W., Cunningham–Rundles, S., Kahn, E., Teichberg, S., Fisher, S. E., & Daum, F. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90626-8 · Cited by 18 · cited 1×
“For example, a decrease of NK cell activity is observed in patients with hereditary colorectal adenocarcinoma 92,93 and melanoma patients with metastatic disease have an impaired perforin-dependent NK cell cytotoxic mechanism.”
Gołąb, J., Zagożdżon, R., Kozar, K., Kamiński, R., Giermasz, A., Stokłosa, T., Lasek, W., & Jakóbisiak, M. (2000) · Oncology Reports · doi:10.3892/or.7.1.177 · Cited by 13 · cited 1×
“Also other cytokines, such as IL-12 and IL-18, synergistically enhance NK cytotoxicity against tumor targets and IFN-γ production by NK cells.(103,104) Tumor-targeted monoclonal antibodies can induce NK cell antibody-dependent cell-mediated cytotoxicity and the rapid degranulation of NK cells results in tumor cell des…”
Hubert, P., Doyen, J., Capelle, X., Arafa, M., Renoux, V., Bisig, B., Seidel, L., Évrard, B., Bousarghin, L., Gerday, C., et al. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00834.x · Cited by 10
Self-citation
Cited by
The Tumor Microenvironment Innately Modulates Cancer Progression
Hinshaw, D. C., & Shevde, L. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3962 · Cited by 3,270
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Abel, A. M., Yang, C., Thakar, M. S., & Malarkannan, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01869 · Cited by 1,150
Immunity, inflammation and cancer: a leading role for adenosine
Antonioli, L., Blandizzi, C., Pacher, P., & Haskó, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3613 · Cited by 765
The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: An overview
Wu, Q., Liu, L., Miron, A., Klímová, B., Wan, D., & Kuča, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1744-5 · Cited by 655
A history of exploring cancer in context
Maman, S., & Witz, I. P. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0006-7 · Cited by 502
Metadata
- Authors
- Jacobs, N., Langers, Renoux, Thiry, & Delvenne
- Venue
- Biologics: Targets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2012-04
- Volume
- 6
- Pages
- 73
- ISSN
- 1177-5475 (ISSN-L)
- OpenAlex
- W1994410743
- Cited by
- 163
- References
- 128
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.